22 November 2022 : Clinical Research
Macronutrients Management for Growth in Neonates with Congenital Gastrointestinal Malformation
Timea E. Brandibur12AC, Aniko Maria Manea12AF, Abhinav Sharma
345BDE, Nilima Rajpal Kundnani 56AE*, Marius Călin Popoiu7D, Bilal Ahmad8B, Diala S. Dahdal 8DEF, Daniela Cioboata2C, Nicoleta Lungu12A, Florina Marinela Doandes12F, Eugen Radu Boia9F, Marioara D. Boia12AD
DOI: 10.12659/MSM.938106
Med Sci Monit 2022; 28:e938106
Table 3 Characteristics of the newborns with stenosis versus the control group.
| Characteristic | OverallN=57* | StenosisN=19* | Control stenosisN=38* | p-value** |
|---|---|---|---|---|
| Sex | >0.9 | |||
| F | 21 (37%) | 7 (37%) | 14 (37%) | |
| M | 36 (63%) | 12 (63%) | 24 (63%) | |
| Weight: baseline | 2,750 (2,060, 3,360) | 2,760 (2,165, 3,325) | 2,750 (2,108, 3,340) | >0.9 |
| Weight: discharge | 3,000 (2,700, 3,520) | 3,210 (2,260, 3,440) | 2,990 (2,742, 3,700) | 0.5 |
| Difference (weight) | 220 (100, 520) | 150 (50, 295) | 270 (138, 580) | 0.060 |
| LOS (days)*** | 11 (6, 18) | 6 (4, 14) | 14 (9, 25) | 0.003 |
| Gestation | >0.9 | |||
| Pre-term | 24 (42%) | 8 (42%) | 16 (42%) | |
| IUGR | 15 (26%) | 5 (26%) | 10 (26%) | |
| Term | 18 (32%) | 6 (32%) | 12 (32%) | |
| Nutrition | >0.9 | |||
| BM | 42 (74%) | 14 (74%) | 28 (74%) | |
| FM | 15 (26%) | 5 (26%) | 10 (26%) | |
| GR | 18 (32%) | 8 (42%) | 10 (26%) | 0.2 |
| Vomiting | 22 (39%) | 15 (79%) | 7 (18%) | <0.001 |
| Abdominal distension | 19 (33%) | 12 (63%) | 7 (18%) | <0.001 |
| * n (%); Median (IQR); ** Pearson’s Chi-squared test; Wilcoxon rank sum test; LOS – length of stay (days); IUGR – intra-uterine growth retardation; BM – breast milk; FM – formula milk; GR – gastric residuals. | ||||